Here's Why CRISPR Stocks Fell in January

Here's Why CRISPR Stocks Fell in January

Source: 
Motley Fool
snippet: 

Spurred by promising clinical results in an important trial, each of the three major CRISPR stocks had a great performance in the second half of 2019. Unfortunately, they didn't keep the momentum going in the first month of 2020.